Crossmark

Toxicity assessment of concurrent gabapentin/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipients

Crossref DOI link: https://doi.org/10.1007/s00520-021-06385-5

Published Online: 2021-06-30

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Angus, Jonathan

Cumpston, Aaron

Veltri, Lauren

Ross, Kelly G.

Wen, Sijin

Dillaman, Megan https://orcid.org/0000-0002-8234-7598
License Information

Text and Data Mining valid from 2021-06-30

Version of Record valid from 2021-06-30
More Information

Article History

Received: 21 April 2021

Accepted: 21 June 2021

First Online: 30 June 2021

Declarations

:

: This study was approved by the institutional review board at West Virginia University Medicine.

: Not applicable – research was retrospective in nature.

: All authors grant final approval of the manuscript draft for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below